Concepedia
Statistics
Publications
21
Citations
995
H-Index
18
Active since
1998
Affiliations
University of Kansas Medical Center(Current)
WuXi AppTec (China)
Array BioPharma (United States)
Theravance Biopharma (United States)
Bristol-Myers Squibb (United States)
Eric B. Harstad is an author at University of Kansas Medical Center specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
1998–2024
Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele
Jacqueline A. Walisser, Maureen K. Bunger, Edward Glover et al. · Journal of Biological Chemistry · 2004 · 121 citations · Full text
Life Sciences, Physiology, Cell Signaling +8
Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1
Yu Zhong, Paula Katavolos, Tien‐Trung Nguyen et al. · Toxicologic Pathology · 2015 · 102 citations · Full text
Medicine, Oncology, Pharmacology +13
Preclinical Development of an Anti-NaPi2b (<i>SLC34A2</i>) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers
Kedan Lin, Bonnee Rubinfeld, Crystal Zhang et al. · Clinical Cancer Research · 2015 · 93 citations
Medicine, Oncology, Pharmacology +14
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design
Xiaojing Wang, Steven Magnuson, Rich Pastor et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 68 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Liver Deformation in Ahr-Null Mice: Evidence for Aberrant Hepatic Perfusion In Early Development
Eric B. Harstad, Christopher A. Guite, Tami L. Thomae et al. · Molecular Pharmacology · 2006 · 65 citations
Medicine, Developmental Biology, Pathology +17
1–5 of 21